Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
G1 Therapeutics Inc (GTHX)  
$4.77 0.21 (4.22%) as of 4:30 Fri 5/10


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 38,010,000
Market Cap: 181.31(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $1.12 - $4.98
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:

   

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  935
Guru Rank Value     : 0
Guru Occurances    : 1

 

            6 Months   1 Year   2 Year  
 
Company Profile   G1 Therapeutics is a commercial-stage biopharmaceutical company focused on the development and commercialization of small molecule therapeutics for the treatment of patients with cancer. Co.'s primary compound trilaciclib is a therapy designed to help protect against chemotherapy-induced myelosuppression. Trilaciclib helps protect hematopoietic stem and progenitor cells in the bone marrow by transiently inhibiting CDK4/6 leading to a temporary arrest of susceptible host cells during chemotherapy in patients. Rintodestrant is an oral selective estrogen receptor degrader for the treatment of ER+ breast cancer.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 35,147 128,372 194,168 376,382
Total Sell Value $151,895 $457,369 $591,564 $2,613,056
Total People Sold 2 6 7 9
Total Sell Transactions 2 14 19 36
End Date 2024-02-11 2023-11-10 2023-05-12 2022-05-12

   
Records found: 328
  Page 6 of 14  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Velleca Mark A.   –       •      –    2021-05-11 4 OE $0.39 $3,900 D/D 10,000 51,000     -
   Malik Rajesh Chief Medical Officer   •       –      –    2021-05-10 4 OE $0.30 $3,000 D/D 10,000 53,300     -
   Malik Rajesh Chief Medical Officer   •       –      –    2021-04-22 4 AS $22.07 $331,100 D/D (15,000) 43,300 -33%     
   Malik Rajesh Chief Medical Officer   •       –      –    2021-04-22 4 OE $0.39 $5,850 D/D 15,000 58,300     -
   Velleca Mark A.   –       •      –    2021-04-15 4 AS $24.96 $249,631 D/D (10,000) 41,000 -43%     
   Velleca Mark A.   –       •      –    2021-04-15 4 OE $0.39 $3,900 D/D 10,000 51,000     -
   Velleca Mark A.   –       •      –    2021-04-14 4 AS $24.53 $245,272 D/D (10,000) 41,000 -42%     
   Velleca Mark A.   –       •      –    2021-04-14 4 OE $0.39 $3,900 D/D 10,000 51,000     -
   Velleca Mark A.   –       •      –    2021-04-13 4 AS $23.89 $238,865 D/D (10,000) 41,000 -44%     
   Velleca Mark A.   –       •      –    2021-04-13 4 OE $0.39 $3,900 D/D 10,000 51,000     -
   Malik Rajesh Chief Medical Officer   •       –      –    2021-03-23 4 AS $21.94 $329,060 D/D (15,000) 43,300 -20%     
   Malik Rajesh Chief Medical Officer   •       –      –    2021-03-23 4 OE $0.39 $5,850 D/D 15,000 58,300     -
   Moses Jennifer K. CFO   •       –      –    2021-03-03 4 OE $3.72 $11,160 D/D 3,000 25,000     -
   Malik Rajesh Chief Medical Officer   •       –      –    2021-03-02 4 AS $22.95 $344,192 D/D (15,000) 43,300 -15%     
   Malik Rajesh Chief Medical Officer   •       –      –    2021-03-02 4 OE $0.39 $23,219 D/D 15,000 58,300     -
   Velleca Mark A.   –       •      –    2021-02-18 4 AS $26.02 $260,152 D/D (10,000) 41,000 -13%     
   Velleca Mark A.   –       •      –    2021-02-18 4 OE $3.72 $37,200 D/D 10,000 51,000     -
   Velleca Mark A.   –       •      –    2021-02-17 4 AS $27.59 $276,433 D/D (10,000) 41,000 -16%     
   Velleca Mark A.   –       •      –    2021-02-17 4 OE $3.72 $37,200 D/D 10,000 51,000     -
   Velleca Mark A.   –       •      –    2021-02-16 4 AS $34.87 $388,653 D/D (11,040) 41,000 -14%     
   Velleca Mark A.   –       •      –    2021-02-16 4 OE $3.72 $41,069 D/D 11,040 52,040     -
   Malik Rajesh Chief Medical Officer   •       –      –    2021-01-27 4 OE $0.39 $1,209 D/D 3,100 43,300     -
   Malik Rajesh Chief Medical Officer   •       –      –    2021-01-22 4 AS $20.64 $309,591 D/D (15,000) 40,200 1%     
   Malik Rajesh Chief Medical Officer   •       –      –    2021-01-22 4 OE $4.17 $62,550 D/D 15,000 55,200     -
   Velleca Mark A.   –       •      –    2021-01-21 4 AS $20.64 $206,400 D/D (10,000) 41,000 1%     

  328 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 6 of 14
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed